BliskoMed, a Polish medtech startup operating in the home medical care sector, has announced that entrepreneurs Tomasz and Piotr Karwatka have joined its investor group. The move underscores growing confidence in the company’s mission to transform how professional medical visits are delivered in domestic settings across Poland.
The Karwatka brothers, established figures in the Polish business landscape, bring their entrepreneurial expertise to the company’s growth phase operations. Their investment decision reflects broader market recognition of the value proposition that BliskoMed offers within the healthtech and medtech sectors.
Addressing Home Healthcare Challenges
BliskoMed operates within a critical segment of the healthcare industry. Professional home medical care remains an essential service, particularly as healthcare systems across Europe seek to reduce hospital admissions and provide more personalized patient experiences. The startup positions itself at the intersection of traditional healthcare delivery and modern service logistics.
The company’s focus on professional home medical visits addresses a specific gap in the market. Rather than centralizing care in clinical settings, BliskoMed’s model brings qualified medical professionals directly to patients’ residences. This approach carries potential benefits for patients requiring ongoing treatment, monitoring, or rehabilitation services who prefer to remain in their home environments.
Investor Backing and Growth Plans
The involvement of the Karwatka brothers represents a significant endorsement of BliskoMed’s operational model and market strategy. At the growth stage, companies in the healthtech space typically require experienced investors who understand both business scaling and the regulatory complexities inherent to medical services.
The injection of capital and business acumen will reportedly support the company’s ongoing development efforts. BliskoMed plans to leverage this backing to expand its home medical care services, though specific financial details regarding the investment amount have not been disclosed publicly.
Broader European Context
The investment comes as European healthtech startups continue attracting attention from both institutional and individual investors. Home healthcare solutions have emerged as a particularly attractive segment within the broader digital health ecosystem. An aging European population combined with rising healthcare costs has created sustained demand for services that enable patients to receive quality care outside traditional hospital and clinic environments.
Poland’s startup ecosystem has demonstrated increasing maturity over recent years, with Polish entrepreneurs and investors becoming more active across multiple sectors. The backing of BliskoMed by experienced local entrepreneurs like the Karwatka brothers illustrates how established business leaders are increasingly channeling resources into innovative health technology ventures.
As European healthcare systems continue navigating resource constraints and rising patient expectations, companies developing home-based medical services may occupy an increasingly important position within the continent’s health infrastructure. BliskoMed’s secured investment suggests that investor confidence in this particular healthcare delivery model continues to strengthen among Polish business leaders.